| INTRODUCTION
Clefts of the lip with or without cleft palate (CL/P) are among the most common human birth defects (Leslie & Marazita, 2013; Marazita, 2012) . Approximately 30% of clefts are syndromic and have co-occurring structural or cognitive anomalies and are caused primarily by chromosomal anomalies or mutations in single genes (Mossey, Little, Munger, Dixon, & Shaw, 2009 ). In contrast, the remaining 70% of CL/P occur in isolation and are considered nonsyndromic (Mossey et al., 2009 ). Nonsyndromic CL/P (NSCL/P) has agenetically complex etiology, caused by multiple interacting genetic and environmental risk factors. Many approaches have been used to identify genetic risk factors for NSCL/P including linkage, candidate gene, and genome-wide association studies (GWAS). Independent GWAS in several different populations and family types have revealed significant genetic heterogeneity with at least 15 genetic loci conferring risk for NSCL/P (Beaty et al., 2010; Birnbaum et al., 2009; Grant et al., 2009; Leslie et al., 2016; Mangold et al., 2010; Sun et al., 2015; Wolf et al., 2015) . For some of these loci, such as IRF6 and NOG, follow-up studies have identified functional variants that may directly influence craniofacial development (Leslie et al., 2015; Rahimov et al., 2008) .
Despite these successes in identifying loci associated with NSCL/P, we estimate these known loci only account for a small proportion (about 20%) of the heritability in any population. GWAS typically focus on single variant analysis of common SNPs (typically with minor allele frequency (MAF) >5%). Other analyses not covered in traditional GWAS have been proposed to identify the "missing heritability" of complex disease including rare variants, copy number variation, and gene × environment and gene × gene interactions. Rare-variant studies for NSCL/P have largely been limited to resequencing of single candidate genes in small samples (Leslie & Murray, 2013) . Although there are many compelling private variants (Jezewski et al., 2003; Leslie et al., 2012; Liu et al., 2016) , there has been only limited support for a burden of rare variants (Al Chawa et al., 2014; Leslie et al., 2012; Suzuki et al., 2009 ). We previously sequenced 13 GWAS or candidate loci in 1,500 case-parent trios and failed to identify a burden of rare variants using several annotation categories. However, an agnostic window-based method identified few regions of over-transmission of rare variants (Leslie et al., 2015) . To date, the only genome-wide study of rare variants has been exome sequencing of 55 distant relative pairs (Bureau et al., 2014) . Therefore, a genome-scale examination of rare variants has not been conducted for NSCL/P.
In this study, we sought to investigate the role of low-frequency coding variants (MAF<1% and MAF<5%) by genotyping 1995 cases and 1626 controls on an exome chip array and performing genebased association tests.
| METHODS

| Study participants
The participants for this study consist of 1995 unrelated cases with NSCL/P and 1626 unrelated controls selected from a larger set of cases, controls, and families recruited from 11 countries across North America, Latin America, Asia, and Europe (Table 1) .
Controls had no known history of orofacial clefts (OFCs) nor other craniofacial anomalies. Cases included probands from unrelated families and unrelated individuals recruited as singleton cases. All sites had local IRB approval as well as approval at the University of Iowa or the University of Pittsburgh.
| Genotyping
Full details of the genotyping, quality control, and imputation were previously described . Briefly, all samples were genotyped for approximately 580,000 SNPs using an Illumina HumanCore + Exome chip with custom content. Quality control included filters for >2% missing call rate, deviations from Hardy-Weinberg Equilibrium (p < 0.0001) in participants with genetically confirmed European ancestry, and monomorphic
SNPs.
Principal components analysis (PCA) was performed for a subset of unrelated participants using a pruned set of 67 K SNPs in low linkage disequilibrium to identify the appropriate principal components (PCs) of ancestry within these data. The resulting eigenvectors were projected onto the remaining set of participants. The resulting PCs strongly tracked global recruitment site and self-reported race/ethnicity. Further, though PCs of ancestry represent orthogonal information across the total multiethnic sample, individual PCs may be highly collinear in specific strata.
Therefore, in addition to the PCs generated across all participants, PCs of ancestry were also generated within each continental group (European, Central/South American, and Asian) for use in stratified analyses.
| SNP selection
To identify the subset of coding variants, we obtained the genomic coordinates for exons of the canonical gene transcripts from the UCSC Genome Browser. All SNPs genotyped on the Illumina HumanCore + Exome chip and located within these exons with at least one observed minor allele and a maximum minor allele frequency of 5% were considered for statistical analyses (totaling 155,361 genotyped variants).
| Imputation of sporadic missingness
We imputed sporadic missing genotypes using the IMPUTE2 software and the 1000 Genomes Project (phase three release) as the reference panel. Imputation accuracy was assessed by masked variant analysis, demonstrating high quality imputation, with mean concordance of 0.995 for SNPs with minor allele frequency (MAF) < 0.05 and 0.960 for SNPs with MAF ≥ 0.05. The "most-likely" genotypes (i.e., genotypes with the highest probability, Q) were selected for statistical analysis if and only if the highest probability was Q > 0.9. Genotypes that could not be imputed to this degree of certainty remained missing in the final analysis.
| Statistical analyses
We tested gene-based association for low-frequency variants using two tests implemented in RVTESTS (Zhan, Hu, Li, Abecasis, & Liu, 2016). The first, the combined multivariate and collapsing (CMC) method, is a burden test that collapses variants into a single score (Li & Leal, 2008) . Because burden tests make the assumption that all variants in the gene have the same direction of effect, we also utilized a second test, the sequence kernel association test (SKAT), which can detect sets of variants with opposite effects (Wu et al., 2011) . The first 18 PCs of ancestry were included in the combined analyses to protect against genomic inflation due to population structure. For stratified analyses, we adjusted for the first five population-specific PCs in Table S2 ).
| RESULTS
We performed analyses of low-frequency variants in our multiethnic population and then stratified into three ancestry groups: Europeans, Latin Americans, and Asians ( Figure 1 , and S1-S4). Two genes achieved genome-wide significance. Variants in N4BP2 with frequencies less than 5% were associated with NSCL/P in the Latin American population (p SKAT.5 = 5.04 × 10 −7
) ( Table 2 , Supplemental Figure S4 ).
The second, PFAS, was associated in all populations combined and in the Latin American subgroup; however, the signal was driven by a single common variant that ultimately failed subsequent quality control checks. When we repeated the analyses excluding this SNP, there was no evidence that PFAS variants are associated with NSCL/P (p = 0.28).
We also examined genes with p values less than 1 × 10 −4 as having suggestive evidence of association (Table 2) . In all populations ). In the Latin American and Asian subgroups, nine and eight suggestive signals were identified, respectively (Table 2) . Among these, several
showed consistent results between CMC and SKAT analyses including CCDC77 in the Latin American group; and SMIM21, CCDC62, and RNU5D in the Asian subgroup. SKAT and CMC both test groups of SNPs in aggregate, but it is possible that not all of the variants are truly contributing to disease. In addition, the aggregated low-frequency variants may not increase risk, but rather appear at higher frequencies in controls, suggesting a protective effect. Therefore, we examined the frequencies of the coding variants in each gene (Supplementary Table S1 ) and performed single variant tests to determine the direction of effect and whether the association signal was driven by a minority of the variants considered in the analysis. Variants in AHRR, CDSN, N4BP2, and PRTG were found at generally higher frequencies in cases compared to controls indicating that low-frequency variants in these genes increase risk of NSCL/P. Of these, N4BP2 was significant only in the MAF <5%
analysis and two variants with MAF >1% appeared to be driving the association. CDSN was also notable in that all five variants had higher frequencies in cases than in controls, but no single variant dominated the signal. With the exception of ALDH5A1, HEATR8, and YEATS2, genes for which the directions of association were unclear, lowfrequency variants in the remaining 15 genes (i.e., SMIM21, CCDC62, DSC1, etc.) were generally found at higher frequencies in controls and therefore appeared to decrease risk for NSCL/P.
We performed functional enrichment analysis on the group of genes surpassing our suggestive p-value threshold. We noted that this gene list was not enriched for Gene Ontology (GO) terms related to molecular functions or biological processes, nor did the genes group into particular pathways. However, two input genes (DSC1 and CDSN)
were annotated for the cellular component GO term "desmosome,"
resulting in a statistical enrichment of the term (p = 4.01 × 10
; Bonferroni adjusted p = 0.02). Interestingly, there was a slight Table S2 ), enrichment analysis returned annotations including "transcription factor," "development," "periderm," and "epithelium." Because the top genes were not enriched for these terms, we may be uncovering new biological factors underlying risk for NSCL/P.
| DISCUSSION
Since the inception of GWAS, the common disease-common variant hypothesis has dominated the search for risk loci for common diseases (Pritchard & Cox, 2002; Reich & Lander, 2001) . As it became clear that common variants only accounted for a portion of the genetic variance, association studies turned to other types of variants and variants with lower minor allele frequencies (Manolio et al., 2009 ). This study was motivated by the fact that multiple GWAS are estimated to account for only 20% of the heritability of NSCL/P. Although there are multiple possible study designs and statistical approaches to address a rarevariant hypothesis, this study focused on tests of low-frequency coding polymorphisms from the Illumina HumanCore + Exome Chip.
This approach is limited to known variants, whereas study designs based on sequencing allow the inclusion of novel variants, that may be private in NSCL/P families. We were unable to identify a large number of genes for which low-frequency variants were strongly associated with NSCL/P; only one, N4BP2, surpassed our genome-wide significance threshold. We identified larger numbers of genes with suggestive evidence of association, particularly within geneticallydefined ancestry groups. This is likely due to increased informativeness of variants within homogenous populations which increases power to detect an association. However, these subgroups are smaller, which simultaneously decreases power. This balance of factors that influence statistical power is particularly important to consider in rarevariant studies, which are notoriously underpowered.
Interestingly, we did not identify associations with known CL/Prisk genes, including those previously implicated in rare variant studies (e.g., MSX1, BMP4, GREM1) (Al Chawa et al., 2014; Leslie & Murray, 2013) . One possible reason for this apparent discrepancy is that previous resequencing studies focused on novel, private variants not | 1535 present on commercial SNP panels while the present study is focused on low-frequency polymorphisms. Another possible reason is that many of the known risk genes are implicated in Mendelian diseases that include syndromic forms of OFCs. These genes tend to be evolutionarily constrained, so we would not expect to find deleterious coding polymorphisms in these genes. However, as OFCs are no longer considered lethal conditions in developed countries, relaxed selection may tolerate higher frequencies of deleterious alleles.
We were unable to identify a suitable replication cohort, as none of the existing GWAS consortia included the ExomeChip. As a consequence, these results should be viewed as preliminary until replicated by independent efforts. However, among our reported associated genes, there are several that could plausibly relate to CL/P risk, based on gene function or expression patterns. Two such genes are DSC1 and CDSN, which were annotated as being part of desmosomes, the intercellular junctions between apposing cells that are essential for mammalian development (Garrod & Chidgey, 2008) .
Desmosomes are composed of the proteins plakoglobin, plakophilin, and a desmosomal cadherin (e.g., desmocollin or desmoglein). DSC1
encodes one of the three desmocollin proteins found in humans. Its expression is confined to stratified epithelia, which includes adult skin and the tongue. In addition, desmosomes include other associated accessory proteins that are necessary for adhesive function, such as corneodesmosin (CDSN), expressed in the epidermis, hair follicle, and hard palate epithelium (Jonca et al., 2011) . Inactivation of Cdsn in mice causes epidermal barrier dysfunction and hair follicle degeneration, resulting in postnatal death (Leclerc et al., 2009) . During palatogenesis, palatal shelves must adhere together prior to disintegration of the medial edge epithelium and formation of a complete palate; this timing coincides with an increase in desmosomes in the medial edge epithelium (Mogass, Bringas, & Shuler, 2000) . Thus an association between variants in these genes and risk of NSCL/P is biologically plausible although the effects of these specific variants are still unknown.
Low-frequency variants in PRTG, N4BP2, and AHRR demonstrated increased risk for NSCL/P. Of these genes, a possible role in craniofacial development is only apparent for PRTG, which encodes protogenin, an immunoglobulin domain-containing receptor involved in survival of rostral cephalic neural crest cells that form osteogenic and chondrogenic cells in the developing face. AHRR (aryl hydrocarbon receptor repressor) and N4BP2 (nedd4 binding protein) do not appear to be strongly expressed in the developing face.
Among the group of genes for which low-frequency variants decreased risk for NSCL/P, there are several interesting genes already implicated in disorders with associated craniofacial features. EHMT1
(euchromatic histone methytransferase 1) mutations and microdeletions cause Kleefstra syndrome in humans, which includes a range of craniofacial dysmorphologies among the associated features (Kleefstra et al., 2006) . Similarly, mutations in KIAA0586 cause a range of ciliopathies, including Joubert syndrome (Alby et al., 2015; Bachmann-Gagescu et al., 2015; Malicdan et al., 2015) . Studies of the mouse and chicken homolog, TALPID3, indicate that the craniofacial defects in TALPID3 mutants are due to impaired hedgehog signaling (Buxton et al., 2004 ). Finally, de novo mutations in POLD1
(DNA polymerase delta) have been reported in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL syndrome) (Weedon et al., 2013 2012-7, 306396/2013-0, 400427/2013-3. 
